Acuta Capital Partners’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-14,000	Closed	-$233K	–	43
2023 Q1	$233K	Buy	+14,000	New	+$233K	0.17%	29
2018 Q3	–	Sell	-750,000	Closed	-$7.12M	–	42
2018 Q2	$7.12M	Buy	+750,000	New	+$7.12M	1.27%	17